Kyntra Bio, Inc. (KYNB)
7.78
-0.24
(-2.99%)
USD |
NASDAQ |
Aug 31, 16:00
7.65
-0.13
(-1.67%)
After-Hours: 20:00
Kyntra Bio Cash from Operations (Annual) : -4.82M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -4.82M |
| December 31, 2024 | -138.00M |
| December 31, 2023 | -315.02M |
| December 31, 2022 | -145.93M |
| December 31, 2021 | -82.23M |
| December 31, 2020 | 81.60M |
| Date | Value |
|---|---|
| December 31, 2019 | -78.70M |
| December 31, 2018 | -76.18M |
| December 31, 2017 | -67.54M |
| December 31, 2016 | 7.108M |
| December 31, 2015 | -18.57M |
| December 31, 2014 | 22.41M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Vericel Corp. | 51.91M |
| Capricor Therapeutics, Inc. | -69.81M |
| ARS Pharmaceuticals, Inc. | -170.87M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |